The Effects of Zolpidem on Akinesia in a Parkinson Disease Patient: A Case Report.
10.4235/jkgs.2015.19.4.241
- Author:
Min Jeong KIM
1
Author Information
1. Department of Neurology, Kosin University College of Medicine, Busan, Korea. merritt329@hanmail.net
- Publication Type:Case Report
- Keywords:
Zolpidem;
Gamma-aminobutyric acid;
Parkinson disease
- MeSH:
Consciousness;
gamma-Aminobutyric Acid;
Humans;
Movement Disorders;
Parkinson Disease*;
Receptors, GABA
- From:Journal of the Korean Geriatrics Society
2015;19(4):241-243
- CountryRepublic of Korea
- Language:English
-
Abstract:
Zolpidem, an imidazopyridine drug that affects the gamma-aminobutyric acid receptor, is typically used as a hypnotic sedative. It has been reported that this drug improves motor symptoms in patients with various movement disorders, including Parkinson disease. We presented a patient with advanced Parkinson disease who demonstrated improved akinesia after taking zolpidem without sleep induction or consciousness changes.
